Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News BD and Lab21 to develop Aspergillus assay for BD Max system

BD and Lab21 to develop Aspergillus assay for BD Max system

9th August 2011

BD is to collaborate with Lab21 on the development of a new molecular diagnostic assay to detect the deadly Aspergillus fungus.

The state-of-the-art device is being created for the BD Max molecular testing system, adding to a pipeline of assay products that now contains more than 14 offerings.

Aspergillus has been identified as a prominent cause of infectious death in immunocompromised patients, threatening around ten million people annually, but early diagnosis can help to greatly reduce fatality rates.

In particular, the real-time polymerase chain reaction principles on which the new BD/Lab21 assay will be based are thought to offer numerous sensitivity and specificity benefits compared to current culture techniques.

Tom Polen, president for diagnostic systems at BD Diagnostics, said: "Our goal is to make the BD Max System an indispensible tool in clinical laboratories by providing them with an ever-expanding test menu on a fully automated platform."

Last month, the company announced that Vincent Forlenza is to become its next president and chief executive officer, replacing the incumbent Edward Ludwig in October 2011.ADNFCR-8000103-ID-800694222-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.